查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1697960

全球分子傳染病檢測市場：市場規模、佔有率、趨勢、產業分析（按產品/服務、類型、檢測類型、疾病、技術、最終用戶和地區）、未來預測（2025-2034）

Molecular Infectious Disease Testing Market Size, Share, Trends, Industry Analysis Report: By Product & Service, Type, Test Type, Disease, Technology, End User, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，分子傳染病檢測市場預計到 2034 年將達到 347.3 億美元。該報告提供了有關當前市場動態的詳細見解，並對未來市場成長進行了分析。

分子傳染病檢測是指檢測和分析病原體遺傳物質的先進診斷技術，能夠準確、早期地識別疾病。分子傳染病檢測市場的關鍵趨勢是擴大採用多重分子診斷方法，這種方法可以在一次測試中同時檢測多種病原體。這項進步將提高診斷效率、縮短週轉時間並改善臨床決策。對快速、廣譜診斷解決方案的需求不斷增長，尤其是在急性護理環境中，這推動了多重檢測進一步融入常規分子檢測，從而加強了其在傳染病管理中的作用。

影響分子傳染病檢測市場需求的另一個主要趨勢是自動化和人工智慧 (AI) 在診斷工作流程中的日益融合。自動化分子檢測平台提高了實驗室效率，最大限度地減少了人為錯誤，並提供了更大的可擴展性以滿足日益增長的檢測需求。人工智慧驅動的數據分析進一步完善了結果的解釋，促進了更準確的診斷和預測分析。自動化和人工智慧的結合簡化了分子診斷，使得整個醫療保健環境中的檢測更加容易和可靠，從而加速了分子傳染病檢測市場的成長。

分子傳染病檢測市場：概述

根據疾病概況，由於性傳染​​病 (STI) 盛行率不斷上升以及對精確和早期診斷解決方案的需求不斷增加，預計性傳染病 (STD) 領域將在 2024 年佔據分子傳染病檢測市場佔有率的首位。

基於產品/服務，由於分子診斷測試在各種醫療保健環境中的使用越來越多，預計試劑和試劑盒部分將在預測期內見證最快的市場成長。

由於北美擁有發達的醫療保健基礎設施、先進診斷技術的高度採用以及支持分子檢測的強大監管框架，預計到 2024 年，北美將成為分子傳染病檢測市場收入佔有率的領先者。

由於醫療保健投資的增加、對早期疾病檢測的認識的提高以及傳染病患者病率的上升，預計亞太地區分子傳染病檢測市場將在預測期內實現最高增長率。

全球市場的主要參與者包括Abbott, Danaher, bioMerieux, Hoffmann-La Roche, Bio-Rad Laboratories, Agilent Technologies, Becton Dickinson, Hologic (Gen-Probe), Illumina, Grifols, Qiagen, Siemens Healthineers, Sysmex, Bruker, Thermo Fisher Scientific。

目錄

第一章簡介

第 2 章執行摘要

第三章 分析方法

第四章 全球分子傳染病檢測市場洞察

  • 市場概況
  • 分子傳染病檢測的市場動態
    • 推動因素和機遇
      • 傳染病增加
      • 分子診斷技術的快速進步
    • 阻礙因素和課題
      • 退款政策不一致
  • PESTLE 分析
  • 分子傳染病檢測市場：分銷通路趨勢
  • 價值鏈分析

5.全球分子傳染病檢測市場（依產品及服務）

  • 主要發現
  • 簡介
  • 試劑和試劑盒
  • 設備
  • 服務軟體

第六章全球分子傳染病檢測市場（按類型）

  • 主要發現
  • 簡介
  • 多重測試
  • 單重測試

7.全球分子傳染病檢測市場（依檢測類型）

  • 主要發現
  • 簡介
  • 實驗室測試
  • 即時檢定

8.全球分子傳染病檢測市場（依疾病類型）

  • 主要發現
  • 簡介
  • 呼吸道感染
  • 胃腸道感染
  • 性傳染病
  • 醫院內感染
  • 陰道炎
  • 腦膜炎
  • 傳播疾病
  • 其他傳染病

第九章：全球分子傳染病檢測市場（依技術）

  • 主要發現
  • 簡介
  • 聚合酶鍊式反應 (PCR)
  • 等溫核酸擴增技術（INACT）
  • DNA定序/次世代定序
  • 原位雜交
  • DNA微陣列
  • 其他

第 10 章。全球分子傳染病檢測市場（依最終用戶劃分）

  • 主要發現
  • 簡介
  • 診斷實驗室
  • 醫院和診所
  • 其他

第 11 章：全球分子傳染病檢測市場（按地區）

  • 主要發現
  • 簡介
    • 分子傳染病檢測市場（按地區）分析（2020-2034）
  • 北美
    • 北美地區（按產品和服務劃分） (2020-2034)
    • 北美，按類型劃分（2020-2034 年）
    • 北美，依測驗類型劃分（2020-2034 年）
    • 北美疾病分類（2020-2034 年）
    • 北美地區技術分類（2020-2034 年）
    • 北美地區最終用戶分佈（2020-2034 年）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依產品與服務（2020-2034 年）
    • 歐洲各類型（2020-2034 年）
    • 歐洲，依測驗類型劃分（2020-2034 年）
    • 歐洲：依疾病分類（2020-2034 年）
    • 歐洲技術分佈（2020-2034）
    • 歐洲最終用戶分佈（2020-2034 年）
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 亞太地區：依產品與服務，2020-2034 年
    • 亞太地區按類型劃分（2020-2034 年）
    • 亞太地區考試類型（2020-2034）
    • 亞太地區：依疾病分類（2020-2034 年）
    • 亞太地區技術分佈（2020-2034）
    • 亞太地區最終用戶分佈（2020-2034）
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
    • 中東和非洲：按產品和服務劃分（2020-2034 年）
    • 中東與非洲：依類型（2020-2034 年）
    • 中東和非洲：按測試類型（2020-2034 年）
    • 中東與非洲：依疾病分類（2020-2034 年）
    • 中東和非洲：依技術分類（2020-2034 年）
    • 中東和非洲：按最終用戶劃分（2020-2034 年）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲依產品與服務劃分（2020-2034 年）
    • 拉丁美洲各類型（2020-2034）
    • 拉丁美洲各測試類型（2020-2034）
    • 拉丁美洲，依疾病分類（2020-2034 年）
    • 拉丁美洲的技術狀況（2020-2034 年）
    • 拉丁美洲最終用戶分佈（2020-2034 年）
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第 12 章 競爭格局

  • 業務擴張與收購分析
    • 業務擴展
    • 收購
  • 夥伴關係/協作/協議/揭露

第 13 章公司簡介

  • Abbott
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Grifols S.A.
  • Hologic, Inc. (Gen-Probe)
  • Illumina, Inc.
  • Qiagen
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific
Product Code: PM5437

The molecular infectious disease testing market size is expected to reach USD 34.73 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Infectious Disease Testing Market Share, Size, Trends, Industry Analysis Report: By Product & Service, Type (Multiplex Testing and Singleplex Testing), Test Type, Disease, Technology, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Molecular infectious disease testing refers to advanced diagnostic techniques that detect and analyze the genetic material of pathogens to enable precise and early disease identification. A major molecular infectious disease testing market trend is the increasing adoption of multiplex molecular diagnostics, which allow the simultaneous detection of multiple pathogens in a single test. This advancement improves diagnostic efficiency, reduces turnaround time, and improves clinical decision-making. The growing demand for rapid and wide diagnostic solutions, particularly in acute care settings, is further driving the integration of multiplex assays into routine molecular testing, strengthening their role in infectious disease management.

Another major trend shaping the molecular infectious disease testing market demand is the rising integration of automation and artificial intelligence (AI) in diagnostic workflows. Automated molecular testing platforms are improving laboratory efficiency, minimizing human errors, and improving scalability to meet the increasing testing demand. AI-driven data analysis is further refining result interpretation, facilitating more accurate diagnoses and predictive analytics. The combination of automation and AI is streamlining molecular diagnostics, making testing more accessible and reliable across various healthcare settings, thereby accelerating molecular infectious disease testing market growth.

Molecular Infectious Disease Testing Market Report Highlights

In terms of disease, the sexually transmitted disease (STD) segment led the molecular infectious disease testing market share in 2024, driven by the rising incidence of STIs and the growing need for precise and early diagnostic solutions.

Based on product & service, the reagents & kits segment is anticipated to experience the most rapid growth in the market during the forecast period, fueled by the increasing utilization of molecular diagnostic tests across various healthcare settings.

North America emerged as the leading region in the global molecular infectious disease testing market revenue share in 2024, attributed to its well-developed healthcare infrastructure, high adoption of advanced diagnostic technologies, and a robust regulatory framework supporting molecular testing.

The molecular infectious disease testing market in Asia Pacific is expected to witness the highest growth rate during the forecast period, driven by expanding healthcare investments, greater awareness of early disease detection, and a rising prevalence of infectious diseases.

A few global key market players include Abbott; Danaher Corporation; bioMerieux SA; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Becton, Dickinson and Company; Hologic, Inc. (Gen-Probe); Illumina, Inc., Grifols S.A.; Qiagen; Siemens Healthineers AG; Sysmex Corporation; Bruker Corporation; and Thermo Fisher Scientific.

Polaris Market Research has segmented the molecular infectious disease testing market report on the basis of product & service, type, test type, disease, technology, end user, and region:

By Product & Service Outlook (Revenue, USD Billion, 2020-2034)

  • Reagents & Kits
  • Instruments
  • Services & Software

By Type Outlook (Revenue, USD Billion, 2020-2034)

  • Multiplex Testing
  • Singleplex Testing

By Test Type Outlook (Revenue, USD Billion, 2020-2034)

  • Laboratory Tests
  • Point-of-Care Tests

By Disease Outlook (Revenue, USD Billion, 2020-2034)

  • Respiratory Infectious Diseases
  • Gastrointestinal Infectious Diseases
  • Sexually Transmitted Diseases
  • Hospital-Acquired Infections
  • Vaginitis
  • Meningitis
  • Vector-Borne Diseases
  • Other Infectious Diseases

By Technology Outlook (Revenue, USD Billion, 2020-2034)

  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • DNA-Sequencing & Next-Generation Sequencing
  • In-Situ Hybridization
  • DNA Microarrays
  • Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Molecular Infectious Disease Testing Market Insights

  • 4.1. Molecular Infectious Disease Testing Market - Distribution Channel Snapshot
  • 4.2. Molecular Infectious Disease Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Cases of Infectious Diseases
      • 4.2.1.2. Rapid Technological Advancements in Molecular Diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Inconsistent Reimbursement Policies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Molecular Infectious Disease Testing Market Distribution Channel Trends
  • 4.6. Value Chain Analysis

5. Global Molecular Infectious Disease Testing Market, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • 5.3. Reagents & Kits
    • 5.3.1. Global Molecular Infectious Disease Testing Market, by Pan-based Molecular Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Molecular Infectious Disease Testing Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 5.5. Services & Software
    • 5.5.1. Global Molecular Infectious Disease Testing Market, by Services & Software, by Region, 2020-2034 (USD Billion)

6. Global Molecular Infectious Disease Testing Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • 6.3. Multiplex Testing
    • 6.3.1. Global Molecular Infectious Disease Testing Market, by Multiplex Testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Singleplex Testing
    • 6.4.1. Global Molecular Infectious Disease Testing Market, by Singleplex Testing, by Region, 2020-2034 (USD Billion)

7. Global Molecular Infectious Disease Testing Market, by Test Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • 7.3. Laboratory Tests
    • 7.3.1. Global Molecular Infectious Disease Testing Market, by Laboratory Tests, by Region, 2020-2034 (USD Billion)
  • 7.4. Point-of-Care Tests
    • 7.4.1. Global Molecular Infectious Disease Testing Market, by Point-of-Care Tests, by Region, 2020-2034 (USD Billion)

8. Global Molecular Infectious Disease Testing Market, by Disease

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • 8.3. Respiratory Infectious Diseases
    • 8.3.1. Global Molecular Infectious Disease Testing Market, by Respiratory Infectious Diseases, by Region, 2020-2034 (USD Billion)
  • 8.4. Gastrointestinal Infectious Diseases
    • 8.4.1. Global Molecular Infectious Disease Testing Market, by Gastrointestinal Infectious Diseases, by Region, 2020-2034 (USD Billion)
  • 8.5. Sexually Transmitted Diseases
    • 8.5.1. Global Molecular Infectious Disease Testing Market, by Sexually Transmitted Diseases, by Region, 2020-2034 (USD Billion)
  • 8.6. Hospital-Acquired Infections
    • 8.6.1. Global Molecular Infectious Disease Testing Market, by Hospital-Acquired Infections, by Region, 2020-2034 (USD Billion)
  • 8.7. Vaginitis
    • 8.7.1. Global Molecular Infectious Disease Testing Market, by Vaginitis Diseases, by Region, 2020-2034 (USD Billion)
  • 8.8. Meningitis
    • 8.8.1. Global Molecular Infectious Disease Testing Market, by Meningitis, by Region, 2020-2034 (USD Billion)
  • 8.9. Vector-Borne Diseases
    • 8.9.1. Global Molecular Infectious Disease Testing Market, by Vector-Borne Diseases, by Region, 2020-2034 (USD Billion)
  • 8.10. Other Infectious Diseases
    • 8.10.1. Global Molecular Infectious Disease Testing Market, by Other Infectious Diseases, by Region, 2020-2034 (USD Billion)

9. Global Molecular Infectious Disease Testing Market, by Technology

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • 9.3. Polymerase Chain Reaction
    • 9.3.1. Global Molecular Infectious Disease Testing Market, by Polymerase Chain Reaction, by Region, 2020-2034 (USD Billion)
  • 9.4. Isothermal Nucleic Acid Amplification Technology
    • 9.4.1. Global Molecular Infectious Disease Testing Market, by Isothermal Nucleic Acid Amplification Technology, by Region, 2020-2034 (USD Billion)
  • 9.5. DNA-Sequencing & Next-Generation Sequencing
    • 9.5.1. Global Molecular Infectious Disease Testing Market, by DNA-Sequencing & Next-Generation Sequencing, by Region, 2020-2034 (USD Billion)
  • 9.6. In-Situ Hybridization
    • 9.6.1. Global Molecular Infectious Disease Testing Market, by In-Situ Hybridization, by Region, 2020-2034 (USD Billion)
  • 9.7. DNA Microarrays
    • 9.7.1. Global Molecular Infectious Disease Testing Market, by DNA Microarrays, by Region, 2020-2034 (USD Billion)
  • 9.8. Others
    • 9.8.1. Global Molecular Infectious Disease Testing Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Molecular Infectious Disease Testing Market, by End User

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 10.3. Diagnostic Laboratories
    • 10.3.1. Global Molecular Infectious Disease Testing Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
  • 10.4. Hospitals & Clinics
    • 10.4.1. Global Molecular Infectious Disease Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
  • 10.5. Others
    • 10.5.1. Global Molecular Infectious Disease Testing Market, by Others, by Region, 2020-2034 (USD Billion)

11. Global Molecular Infectious Disease Testing Market, by Geography

  • 11.1. Key Findings
  • 11.2. Introduction
    • 11.2.1. Molecular Infectious Disease Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 11.3. Molecular Infectious Disease Testing Market - North America
    • 11.3.1. North America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.3.2. North America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.3.3. North America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.3.4. North America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.3.5. North America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.3.6. North America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.3.7. Molecular Infectious Disease Testing Market - US
      • 11.3.7.1. US: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.3.7.2. US: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.3.7.3. US: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.3.7.4. US: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.3.7.5. US: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.3.7.6. US: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.3.8. Molecular Infectious Disease Testing Market - Canada
      • 11.3.8.1. Canada: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.3.8.2. Canada: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.3.8.3. Canada: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.3.8.4. Canada: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.3.8.5. Canada: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.3.8.6. Canada: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.4. Molecular Infectious Disease Testing Market - Europe
    • 11.4.1. Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.4.2. Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.4.3. Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.4.4. Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.4.5. Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.4.6. Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.7. Molecular Infectious Disease Testing Market - UK
      • 11.4.7.1. UK: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.7.2. UK: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.7.3. UK: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.7.4. UK: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.7.5. UK: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.7.6. UK: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.8. Molecular Infectious Disease Testing Market - France
      • 11.4.8.1. France: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.8.2. France: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.8.3. France: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.8.4. France: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.8.5. France: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.8.6. France: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.9. Molecular Infectious Disease Testing Market - Germany
      • 11.4.9.1. Germany: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.9.2. Germany: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.9.3. Germany: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.9.4. Germany: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.9.5. Germany: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.9.6. Germany: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.10. Molecular Infectious Disease Testing Market - Italy
      • 11.4.10.1. Italy: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.10.2. Italy: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.10.3. Italy: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.10.4. Italy: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.10.5. Italy: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.10.6. Italy: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.11. Molecular Infectious Disease Testing Market - Spain
      • 11.4.11.1. Spain: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.11.2. Spain: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.11.3. Spain: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.11.4. Spain: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.11.5. Spain: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.11.6. Spain: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.12. Molecular Infectious Disease Testing Market - Netherlands
      • 11.4.12.1. Netherlands: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.12.2. Netherlands: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.12.3. Netherlands: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.12.4. Netherlands: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.12.5. Netherlands: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.12.6. Netherlands: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.13. Molecular Infectious Disease Testing Market - Russia
      • 11.4.13.1. Russia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.13.2. Russia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.13.3. Russia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.13.4. Russia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.13.5. Russia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.13.6. Russia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.4.14. Molecular Infectious Disease Testing Market - Rest of Europe
      • 11.4.14.1. Rest of Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.4.14.2. Rest of Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.4.14.3. Rest of Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.4.14.4. Rest of Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.4.14.5. Rest of Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.4.14.6. Rest of Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.5. Molecular Infectious Disease Testing Market - Asia Pacific
    • 11.5.1. Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.5.2. Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.5.3. Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.5.4. Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.5.5. Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.5.6. Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.7. Molecular Infectious Disease Testing Market - China
      • 11.5.7.1. China: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.7.2. China: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.7.3. China: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.7.4. China: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.7.5. China: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.7.6. China: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.8. Molecular Infectious Disease Testing Market - India
      • 11.5.8.1. India: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.8.2. India: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.8.3. India: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.8.4. India: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.8.5. India: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.8.6. India: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.9. Molecular Infectious Disease Testing Market - Malaysia
      • 11.5.9.1. Malaysia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.9.2. Malaysia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.9.3. Malaysia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.9.4. Malaysia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.9.5. Malaysia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.9.6. Malaysia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.10. Molecular Infectious Disease Testing Market - Japan
      • 11.5.10.1. Japan: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.10.2. Japan: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.10.3. Japan: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.10.4. Japan: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.10.5. Japan: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.10.6. Japan: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.11. Molecular Infectious Disease Testing Market - Indonesia
      • 11.5.11.1. Indonesia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.11.2. Indonesia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.11.3. Indonesia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.11.4. Indonesia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.11.5. Indonesia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.11.6. Indonesia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.12. Molecular Infectious Disease Testing Market - South Korea
      • 11.5.12.1. South Korea: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.12.2. South Korea: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.12.3. South Korea: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.12.4. South Korea: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.12.5. South Korea: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.12.6. South Korea: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.13. Molecular Infectious Disease Testing Market - Australia
      • 11.5.13.1. Australia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.13.2. Australia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.13.3. Australia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.13.4. Australia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.13.5. Australia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.13.6. Australia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.5.14. Molecular Infectious Disease Testing Market - Rest of Asia Pacific
      • 11.5.14.1. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.5.14.2. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.5.14.3. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.5.14.4. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.5.14.5. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.5.14.6. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.6. Molecular Infectious Disease Testing Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.6.2. Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.6.3. Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.6.4. Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.6.5. Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.6.6. Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.7. Molecular Infectious Disease Testing Market - Saudi Arabia
      • 11.6.7.1. Saudi Arabia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.7.2. Saudi Arabia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.7.3. Saudi Arabia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.7.4. Saudi Arabia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.7.5. Saudi Arabia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.7.6. Saudi Arabia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.8. Molecular Infectious Disease Testing Market - UAE
      • 11.6.8.1. UAE: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.8.2. UAE: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.8.3. UAE: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.8.4. UAE: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.8.5. UAE: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.8.6. UAE: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.9. Molecular Infectious Disease Testing Market - Israel
      • 11.6.9.1. Israel: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.9.2. Israel: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.9.3. Israel: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.9.4. Israel: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.9.5. Israel: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.9.6. Israel: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.10. Molecular Infectious Disease Testing Market - South Africa
      • 11.6.10.1. South Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.10.2. South Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.10.3. South Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.10.4. South Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.10.5. South Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.10.6. South Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.6.11. Molecular Infectious Disease Testing Market - Rest of Middle East & Africa
      • 11.6.11.1. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.6.11.2. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.6.11.3. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.6.11.4. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.6.11.5. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.6.11.6. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • 11.7. Molecular Infectious Disease Testing Market - Latin America
    • 11.7.1. Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
    • 11.7.2. Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
    • 11.7.3. Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
    • 11.7.4. Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
    • 11.7.5. Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
    • 11.7.6. Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.7.7. Molecular Infectious Disease Testing Market - Mexico
      • 11.7.7.1. Mexico: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.7.7.2. Mexico: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.7.7.3. Mexico: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.7.7.4. Mexico: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.7.7.5. Mexico: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.7.7.6. Mexico: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.7.8. Molecular Infectious Disease Testing Market - Brazil
      • 11.7.8.1. Brazil: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.7.8.2. Brazil: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.7.8.3. Brazil: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.7.8.4. Brazil: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.7.8.5. Brazil: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.7.8.6. Brazil: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.7.9. Molecular Infectious Disease Testing Market - Argentina
      • 11.7.9.1. Argentina: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.7.9.2. Argentina: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.7.9.3. Argentina: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.7.9.4. Argentina: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.7.9.5. Argentina: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.7.9.6. Argentina: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
    • 11.7.10. Molecular Infectious Disease Testing Market - Rest of Latin America
      • 11.7.10.1. Rest of Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
      • 11.7.10.2. Rest of Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
      • 11.7.10.3. Rest of Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
      • 11.7.10.4. Rest of Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
      • 11.7.10.5. Rest of Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
      • 11.7.10.6. Rest of Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
    • 12.1.2. Acquisitions
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Abbott
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. Agilent Technologies, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. Becton, Dickinson and Company
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. bioMérieux SA
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Bio-Rad Laboratories, Inc.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. Bruker Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. Danaher Corporation
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. F. Hoffmann-La Roche Ltd
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. Grifols S.A.
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. Hologic, Inc. (Gen-Probe)
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development
  • 13.11. Illumina, Inc.
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Benchmarking
    • 13.11.4. Recent Development
  • 13.12. Qiagen
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Benchmarking
    • 13.12.4. Recent Development
  • 13.13. Siemens Healthineers AG
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Benchmarking
    • 13.13.4. Recent Development
  • 13.14. Sysmex Corporation
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Benchmarking
    • 13.14.4. Recent Development
  • 13.15. Thermo Fisher Scientific
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Benchmarking
    • 13.15.4. Recent Development

List of Tables:

  • Table 1 Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 2 Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 3 Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 4 UK: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 5 UK: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 6 UK: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 7 UK: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 8 UK: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 9 UK: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 10 France: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 11 France: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 12 France: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 13 France: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 14 France: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 15 France: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 16 Germany: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 17 Germany: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Germany: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 19 Germany: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 20 Germany: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 21 Germany: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Italy: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 23 Italy: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 24 Italy: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 25 Italy: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 26 Italy: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 27 Italy: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 29 Spain: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 30 Spain: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 31 Spain: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 32 Spain: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 33 Spain: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Netherlands: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 35 Netherlands: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 36 Netherlands: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 37 Netherlands: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 38 Netherlands: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 39 Netherlands: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Russia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 41 Russia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Russia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 43 Russia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 44 Russia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 45 Russia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 46 Rest of Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 47 Rest of Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Rest of Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 57 Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 58 China: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 59 China: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 60 China: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 61 China: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 62 China: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 63 China: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 64 India: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 65 India: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 66 India: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 67 India: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 68 India: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 69 India: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Malaysia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 71 Malaysia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 72 Malaysia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 73 Malaysia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 74 Malaysia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 75 Malaysia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Japan: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 77 Japan: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 78 Japan: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 79 Japan: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 80 Japan: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 81 Japan: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Indonesia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 83 Indonesia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 84 Indonesia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 85 Indonesia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 86 Indonesia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 87 Indonesia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 88 South Korea: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 89 South Korea: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 90 South Korea: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 91 South Korea: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 92 South Korea: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 93 South Korea: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Australia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 95 Australia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 96 Australia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 97 Australia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 98 Australia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 99 Australia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 100 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 101 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 103 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 104 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 105 Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 106 Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 107 Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 108 Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 109 Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 110 Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 112 Saudi Arabia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 113 Saudi Arabia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 114 Saudi Arabia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 115 Saudi Arabia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 118 UAE: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 119 UAE: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 120 UAE: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 121 UAE: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 122 UAE: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 123 UAE: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 124 Israel: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 125 Israel: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 126 Israel: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 128 Israel: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 129 Israel: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 130 South Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 131 South Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 133 South Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 134 South Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 135 South Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 141 Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 142 Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 143 Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 144 Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 145 Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 146 Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 147 Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 148 Mexico: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 149 Mexico: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 150 Mexico: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 151 Mexico: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 152 Mexico: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 153 Mexico: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 154 Brazil: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 155 Brazil: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 156 Brazil: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 157 Brazil: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 158 Brazil: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 159 Brazil: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 160 Argentina: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 161 Argentina: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 162 Argentina: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 163 Argentina: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 164 Argentina: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 165 Argentina: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
  • Table 166 Rest of Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
  • Table 167 Rest of Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 168 Rest of Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
  • Table 169 Rest of Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
  • Table 170 Rest of Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
  • Table 171 Rest of Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Molecular Infectious Disease Testing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product & Service
  • Figure 7. Global Molecular Infectious Disease Testing Market, by Product & Service, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Molecular Infectious Disease Testing Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Test Type
  • Figure 11. Global Molecular Infectious Disease Testing Market, by Test Type, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Disease
  • Figure 13. Global Molecular Infectious Disease Testing Market, by Disease, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Technology
  • Figure 15. Global Molecular Infectious Disease Testing Market, by Technology, 2024 & 2034 (USD Billion)
  • Figure 16. Market by End User
  • Figure 17. Global Molecular Infectious Disease Testing Market, by End User, 2024 & 2034 (USD Billion)